New heart valve fix without open surgery: early trial begins
NCT ID NCT07501234
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study is testing a new device called MitraFix® for people with a severe leaky heart valve (mitral regurgitation) who are too high-risk for open-heart surgery. The device is implanted through a small tube in a leg vein. The main goals are to see if the procedure is safe and if the valve works properly. Only 5 participants will be enrolled and followed for one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
MitraFix® Transcatheter Mitral Valve System (a device implanted via a leg vein to replace a leaky heart valve)
What this could lead to
If it works, this could offer a less invasive option for people with a severe leaky heart valve who are too frail for open-heart surgery.
What could go wrong
This is a very early feasibility study with only 5 participants, so results may not apply to everyone. The device might not reduce the leak enough or could cause complications like stroke or need for re-operation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MITRAL REGURGITATION (MR) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fuwai Hospital, Chinese Academy of Medical Sciences
RECRUITINGBeijing, Beijing Municipality, 100037, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact